Irtiza Sheikh, DO, sought to assess the impact of age and clinical setting on liso-cel efficacy in patients with large B-cell lymphoma.
Irtiza N. Sheikh, DO
Advertisement
Articles by Irtiza N. Sheikh, DO
Researchers and clinicians share key updates in leukemia, lymphoma, and myelodysplastic syndrome that they presented at the 2026 Tandem Meetings.
Irtiza N. Sheikh, DO, hopes liso-cel accessibility increases in non-clinical trial settings and is considered for use earlier in the LBCL treatment course.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Endometrial Cancer Treatment Options: What are the Experts Using?
2
LITESPARK-011 Regimen: Potentially A New SOC in PD-1 Pretreated ccRCC?
3
Frontline IO-Combos, Next-Generation ADCs: Evolutions in Endometrial Cancer
4
Managing Relapsed/Refractory Follicular Lymphoma: Overview and Unmet Needs
5